QINLOCK

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 73207-101
  • Package NDC 73207-101-30
  • Package NDC 73207-101-31
  • Application number NDA213973
  • SPL ID 142c8672-a552-4d20-9226-2a92aa9773d1
  • SPL set ID 9f18e462-03dd-4296-a02a-a0577e3ee78d
  • UNII 9XW757O13D
  • RxCUI 2369397
  • RxCUI 2369403

What the source publishes

Labeler
Deciphera Pharmaceuticals, LLC
Active ingredients
Ripretinib
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:73207-101_142c8672-a552-4d20-9226-2a92aa9773d1
{
  "name": "QINLOCK",
  "splId": "142c8672-a552-4d20-9226-2a92aa9773d1",
  "labels": [
    {
      "setId": "9f18e462-03dd-4296-a02a-a0577e3ee78d",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f18e462-03dd-4296-a02a-a0577e3ee78d",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f18e462-03dd-4296-a02a-a0577e3ee78d"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Deciphera Pharmaceuticals, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE in 1 CARTON (73207-101-30)  / 90 TABLET in 1 BOTTLE",
      "package_ndc": "73207-101-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200515"
    },
    {
      "sample": true,
      "description": "1 BOTTLE in 1 CARTON (73207-101-31)  / 30 TABLET in 1 BOTTLE",
      "package_ndc": "73207-101-31",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200515"
    }
  ],
  "productId": "73207-101_142c8672-a552-4d20-9226-2a92aa9773d1",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "73207-101",
  "deaSchedule": null,
  "genericName": "Ripretinib",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RIPRETINIB",
      "strength": "50 mg/1"
    }
  ],
  "applicationNumber": "NDA213973",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200515",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175605",
      "N0000020034",
      "N0000020028",
      "N0000187062",
      "N0000185503",
      "N0000190113"
    ],
    "unii": [
      "9XW757O13D"
    ],
    "rxcui": [
      "2369397",
      "2369403"
    ],
    "spl_set_id": [
      "9f18e462-03dd-4296-a02a-a0577e3ee78d"
    ],
    "pharm_class_epc": [
      "Kinase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Stem Cell Factor (KIT) Receptor Inhibitors [MoA]",
      "Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]",
      "Cytochrome P450 2C8 Inhibitors [MoA]",
      "P-Glycoprotein Inhibitors [MoA]",
      "Breast Cancer Resistance Protein Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Deciphera Pharmaceuticals, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:73207-101_142c8672-a552-4d20-9226-2a92aa9773d1"